Transplantation of NNCI cells after experimental stroke

• Autorzy: Braun H. , Baldauf K. , Paul G. , Brundin P. , Reymann K.
• Języki publikacji: EN

Abstrakty

EN

Transplantation of stem cells is currently investigated as an option for treatment of stroke. In this study we transplanted adult human cells NNC1 derived from brain biopsy after experimental stroke in rats. Transient ischemia in rats was performed by the fi lament model of middle cerebral artery occlusion (fMCAO). About 3×105 NNC1 cells were transplanted near to the necrotic area 7 days after fMCAO and the brain of treated rats was investigated 4 weeks after transplantation. Rats were immunosuppressed by daily injections of cyclosporine A, prednisolone and azathioprine. Grafted cells were localized by anti-human specifi c antibodies HuNu and MTC02. Cells appeared to be located dispersed, however there was almost no cell-migration. The number of localized NNC1 cells 4 weeks after transplantation was rather limited indicating a reduced survival rate which was probably caused by host versus graft rejection processes. The latter is refl ected by activation of Ox42 and ED1 positive microglia/macrophages. Also, we detected CD8 and TCR positive T-cells infi ltrating to the necrotic area. Immunocytochemical analysis revealed expression of nestin and βIII-tubulin by grafted NNC1. Interestingly, some βIII tubulin expressing NNC1 were found to be located in blood vessels. In conclusion, both the survival and the capacity to neuronal differentiation of grafted NNC1 cells are limited.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2009
• Tom: 69
• Numer: 3
• Opis fizyczny: p.294

Twórcy

autor

Braun H.

• Department of Neuropharmacology, Leibniz Institute for Neurobiology, Magdeburg, Germany

autor

Baldauf K.

• Department of Neuropharmacology, Leibniz Institute for Neurobiology, Magdeburg, Germany

autor

Paul G.

• Department of Neuronal Survival Unit, Wallenberg, Neuroscience Center, Lund, Sweden

autor

Brundin P.

• Department of Neuronal Survival Unit, Wallenberg, Neuroscience Center, Lund, Sweden

autor

Reymann K.

• Department of Neuropharmacology, Leibniz Institute for Neurobiology, Magdeburg, Germany